TEGA Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

TEGA Therapeutics General Information

Description

Developer of a healthcare technology intended to treat lysosomal storage disorders. The company's technology uses glycoscience-related therapies to enhance the delivery of enzyme replacement therapies to the brain and produces bio-engineered heparan sulfate, enabling patients to receive treatments for unmet life-threatening medical needs.

Contact Information

Website
www.tegatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3550 General Atomics Court
  • Suite G02-102
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
E-Commerce, HealthTech, Life Sciences
Corporate Office
  • 3550 General Atomics Court
  • Suite G02-102
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TEGA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private Completed Generating Revenue
7. Grant 05-Feb-2022 Completed Generating Revenue
6. Grant 01-Jan-2021 Completed Generating Revenue
5. Grant 15-Dec-2020 Completed Generating Revenue
4. Grant 31-Jan-2019 Completed Generating Revenue
3. Early Stage VC 01-Mar-2018 Completed Generating Revenue
2. Grant 20-Jun-2016 $270K Completed Generating Revenue
1. University Spin-Out 01-Mar-2014 Completed Generating Revenue
To view TEGA Therapeutics’s complete valuation and funding history, request access »

TEGA Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare technology intended to treat lysosomal storage disorders. The company's technology uses glycos
Drug Discovery
San Diego, CA
10 As of 2025

San Rafael, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TEGA Therapeutics Competitors (1)

One of TEGA Therapeutics’s competitors is BioMarin Pharmaceutical, a Formerly PE-Backed company based in San Rafael, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
You’re viewing 1 of 1 competitors. Get the full list »

TEGA Therapeutics Patents

  • 23

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

TEGA Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240301092-A1 Heparin from modified mst cells and methods of making and using Pending 29-Jun-2021
WO-2023278631-A1 Heparin from modified mst cells and methods of making and using Inactive 29-Jun-2021
AU-2020336112-A1 Heparin and heparan sulfate from modified mst cells and methods of making and using Inactive 27-Aug-2019
AU-2026204240-A1 Heparin and heparan sulfate from modified mst cells and methods of making and using Pending 27-Aug-2019
CA-3152781-A1 Heparin and heparan sulfate from modified mst cells and methods of making and using Pending 27-Aug-2019 A61K31/727
To view TEGA Therapeutics’s complete patent history, request access »

TEGA Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TEGA Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
U.S. Department of Health and Human Services Government
Angel (individual) Minority
Sea Purity Investments Family Office Minority
TCA Venture Group Angel Group Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

TEGA Therapeutics FAQs

  • When was TEGA Therapeutics founded?

    TEGA Therapeutics was founded in 2014.

  • Where is TEGA Therapeutics headquartered?

    TEGA Therapeutics is headquartered in San Diego, CA.

  • What is the size of TEGA Therapeutics?

    TEGA Therapeutics has 10 total employees.

  • What industry is TEGA Therapeutics in?

    TEGA Therapeutics’s primary industry is Drug Discovery.

  • Is TEGA Therapeutics a private or public company?

    TEGA Therapeutics is a Private company.

  • What is TEGA Therapeutics’s current revenue?

    The current revenue for TEGA Therapeutics is .

  • Who are TEGA Therapeutics’s investors?

    National Institutes of Health, U.S. Department of Health and Human Services, , Sea Purity Investments, and TCA Venture Group are 5 of 7 investors who have invested in TEGA Therapeutics.

  • Who are TEGA Therapeutics’s competitors?

    BioMarin Pharmaceutical is a competitor of TEGA Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process